PTGS2 and neoplasm: In vivo studies also found significant reduction of tumor growth (p < 0.05) at 30 mg/kg without any sign of toxicity in comparison to negative control group (DMSO) as well as decreased expression of p50 NF-κB and COX-2 in tumor tissue.